Monday, Nov 4, 2024 · SEC filings
What the smart money revealed on Nov 4
572 insider filings came in. We hid 82 planned (10b5-1) sellers and 363 people whose filings were routine, like grants and tax withholding.
4 insiders at MSD Investment bought $950K of stock
Roles: Officer, Director. Several insiders buying in the same few days is rare.
4 insiders at MAIA Biotechnology (MAIA) bought $584K of stock
Roles: Director. Several insiders buying in the same few days is rare.
SS Innovations International (SSII) Director Timothy Adams bought $2.04M
1.4M shares on the open market. Not a grant or an option exercise.
Columbus McKinnon (CMCO) President and CEO David Wilson bought $1M
31,300 shares on the open market. Not a grant or an option exercise.
Palladyne AI (PDYN) Director Dennis Weibling bought $473K
215,053 shares on the open market. Not a grant or an option exercise.
Palladyne AI (PDYN) President and CEO Benjamin Wolff bought $237K
107,526 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 4 checked quarters beat the typical stock 6 months later.
Altice USA (OPTU) Director Patrick Drahi sold $19.7M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 34.83M shares.
United Therapeutics (UTHR) President and COO Michael Benkowitz sold $5.5M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day.
Cactus (WHD) EVP and CEO of Spoolable Tech Stephen Tadlock sold $2.06M
Not marked as a planned 10b5-1 sale. Sold 48% of the shares they held directly. Still holds 36,357 shares.
Show 29 more real buys
Show 42 more real sales
13F season
Holdings as of Sep 30, 2024 are due Nov 14
58 funds have filed so far. 54 filed for the quarter before.
Biggest real insider buys, Oct 29–Nov 4
Open-market buys by officers and directors, filed in the 7 days up to Nov 4.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.